Literature DB >> 8911294

CMAJ endorses the CONSORT statement. CONsolidation of Standards for Reporting Trials.

P Huston1, J Hoey.   

Abstract

Mesh：

Year:  1996        PMID： 8911294      PMCID： PMC1335069     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  18 in total

1.  A consumer's guide to subgroup analyses.

Authors:  A D Oxman; G H Guyatt
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

Review 2.  A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989.

Authors:  A Donner; K S Brown; P Brasher
Journal:  Int J Epidemiol       Date:  1990-12       Impact factor: 7.196

3.  Ascorbic acid for the common cold. A prophylactic and therapeutic trial.

Authors:  T R Karlowski; T C Chalmers; L D Frenkel; A Z Kapikian; T L Lewis; J M Lynch
Journal:  JAMA       Date:  1975-03-10       Impact factor: 56.272

4.  Analysis of clinical trials by treatment actually received: is it really an option?

Authors:  Y J Lee; J H Ellenberg; D G Hirtz; K B Nelson
Journal:  Stat Med       Date:  1991-10       Impact factor: 2.373

5.  An exploratory study of statistical assessment of papers published in the British Medical Journal.

Authors:  M J Gardner; J Bond
Journal:  JAMA       Date:  1990-03-09       Impact factor: 56.272

6.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

7.  Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations.

Authors:  J C Bailar; F Mosteller
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

8.  Statistical power, sample size, and their reporting in randomized controlled trials.

Authors:  D Moher; C S Dulberg; G A Wells
Journal:  JAMA       Date:  1994-07-13       Impact factor: 56.272

9.  Trials on trial. A review of trials of antibiotic prophylaxis.

Authors:  M Evans; A V Pollock
Journal:  Arch Surg       Date:  1984-01

10.  Statistics in practice. Comparing the means of several groups.

Authors:  K Godfrey
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245
View more
  6 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  David Moher; Kenneth F Schulz; Douglas G Altman
Journal:  Clin Oral Investig       Date:  2003-01-31       Impact factor: 3.573

Review 2.  [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

3.  Clinical trials in urogynecology.

Authors:  D Moher
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

4.  Unvarnished viewpoints and scientific scrutiny. Letter to the editor provide a forum for readers and help make a journal accountable to the medical community.

Authors:  C J Brown
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

5.  Methodological quality and reporting of ethical requirements in phase III cancer trials.

Authors:  J J Tuech; P Pessaux; G Moutel; V Thoma; S Schraub; C Herve
Journal:  J Med Ethics       Date:  2005-05       Impact factor: 2.903

6.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  BMC Med Res Methodol       Date:  2001-04-20       Impact factor: 4.615
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.